P1.171. Salvage Esophagectomy Outcomes After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: A 45-Patients Indian Single-Center Experience

Clicks: 19
ID: 326174
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #291 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background The SANO trial demonstrated non-inferior 2-year overall survival with active surveillance versus immediate surgery in patients achieving clinical complete response after neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, with ~40% eventually requiring salvage esophagectomy for locoregional regrowth. Data on salvage outcomes in SCC-dominant Indian cohorts under resource-variable surveillance remain limited. Methods Retrospective review of 45 consecutive patients with biopsy-proven esophageal squamous cell carcinoma undergoing salvage esophagectomy for persistent or recurrent locoregional disease after nCRT (CROSS regimen) at a high-volume Delhi center (2019–2025). Robotic approach in 33 (73%), open in 12 (27%). Primary endpoints: R0 resection rate, major morbidity (Clavien-Dindo ≥III), perioperative mortality, and survival. Results Median age 58 years, 71% male. Median time from nCRT completion to salvage surgery: 5.3 months (IQR 3.8–7.2). R0 resection achieved in 39 (87%); pathologic complete response in 8 (18%). Major complications occurred in 14 (31%), including anastomotic leak (20%, n=9) and pulmonary events (27%, n=12). In-hospital mortality 2% (n=1); 90-day mortality 7% (n=3). Median follow-up 28 months; 2-year overall survival 64%, 3-year overall survival 47%. Conclusion Salvage esophagectomy in this Indian SCC series yielded high R0 rates, acceptable morbidity, low mortality, and survival comparable to SANO salvage subsets. Robotic techniques proved safe and feasible. These results support implementation of SANO-style active surveillance in SCC-predominant settings with prompt access to high-quality minimally invasive salvage surgery.
Reference Key
openalex_W7204005505 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors B Manish Kumar
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.319
URL
https://academic.oup.com/dote/article-pdf/39/Supplement_1/doag077.319/70760401/doag077.319.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.